European Journal of Clinical Pharmacology

, Volume 43, Issue 6, pp 621–623 | Cite as

Acetylator phenotypes of Jordanian diabetics

  • Y. Irshaid
  • H. Al-Hadidi
  • M. Abuirjeie
  • A. Latif
  • O. Sartawi
  • N. Rawashdeh
Originals

Summary

The acetylator phenotype was determined in 31 insulin-dependent (IDDM) and 110 noninsulin-dependent (NIDDM) Jordanian diabetics, and was compared to that of 160 healthy volunteers of the same ethnic group. Dapsone was used as the test drug.

The rapid acetylator phenotype was slightly less frequent in IDDM and slightly more frequent in NIDDM. Neither of the differences was significant. When acetylator status in the two types of diabetes mellitus was compared, there was a significant difference among the two groups.

Patients with IDDM had a higher percentage of the slow acetylator phenotype when compared to NIDDM patients. The association between acetylator status and IDDM in Jordanians, which agrees with that reported for the Saudi Arabian population, is the reverse of what is found in European populations.

The results demonstrate ethnic differences in acetylator status among IDDM patients.

Key words

Acetylation, Diabetes mellitus Jordanians, phenotype, dapsone, ethnic differences 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Weber WW, Hein DW (1985) N-acetylation pharmacogenetics. Pharmacol Rev 37: 25–79Google Scholar
  2. 2.
    Evans DAP, Manley KA, McKusick VA (1960) Genetic control of isoniazid metabolism in man. Br Med J 2: 458–491Google Scholar
  3. 3.
    Ladero JM, Jemenez LC, Fernandez MJ, Robledo A (1988) Acetylator polymorphism in discoid lupus erythematosus. Eur J Clin Pharmacol 34: 307–308Google Scholar
  4. 4.
    Hein DW (1988) Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 948: 37–66Google Scholar
  5. 5.
    Burrows AW, Hockaday TDR, Mann JI, Taylor JG (1978) Diabetic dimorphism according to acetylator status. Br Med J 1: 208–210Google Scholar
  6. 6.
    Bodansky HJ, Drury PL, Cudworth AG, Evans DAP (1981) Acetylator phenotypes and type I (insulin-dependent) diabetics with microvascular disease. Diabetes 30: 907–910Google Scholar
  7. 7.
    Shenfield GM, McCann VJ, Tjokresetio R (1982) Acetylator status and diabetic neuropathy. Diabetologia 22:441–444Google Scholar
  8. 8.
    Pontiroli AE, Mosca A, de Pasqua A, Alcini D, Pozza G (1984) The fast acetylator phenotype in diabetes mellitus: abnormal prevalence and association with the ABO blood groups Diabetologia 27: 235–237Google Scholar
  9. 9.
    Stryjek-Kaminska D, Malczewski B, Kopec A, Rowinska-Marcinska K (1988) Acetylator phenotypes in diabetes mellitus. Acta Diabetol Lat 25: 41–48Google Scholar
  10. 10.
    Evans DAP, Paterson S, Francisco P, Alvarez G (1985) The acetylator phenotypes of Saudi Arabian Diabetics. J Med Genet 22: 479–483Google Scholar
  11. 11.
    National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057Google Scholar
  12. 12.
    Irshaid, YM, Al-Hadidi HF, Abuirjeie MA, Rawashdeh NM (1991) N-acetylation phenotyping using dapsone in a Jordanian population. Br J Clin Pharmacol 32: 289–293Google Scholar
  13. 13.
    Abuirjeie MA, Irshaid YM, Al-Hadidi HF, Rawashdeh NM (1991) Simultaneous high performance liquid chromatographic determination of dapsone and monoacetyldapsone in human plasma and urine. J Clin Pharm Therap 16: 247–255Google Scholar
  14. 14.
    Rosner B (1982) Fundamentals of Biostatistics. Duxbury Press, Boston, MassachusettsGoogle Scholar
  15. 15.
    Gardner MJ, Altman DG (1986) Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J 292: 746–750Google Scholar
  16. 16.
    Ladero JM, Arrojo A, de Salamanca RE, Gomez M, Cano F, Alfonso M (1982) Hepatic acetylator phenotype in diabetes mellitus. Ann Clin Res 14: 187–189Google Scholar
  17. 17.
    Hadasova E, Brysova V, Kadlcakova E (1990) N-acetylation in healthy and diseased children. Eur J Clin Pharmacol 39(1): 43–47Google Scholar
  18. 18.
    Thom S, Farrow PR, Samoso B, Alberti KGMM, Rawlins MD (1981) Effects of oral glucose in lime juice on isoniazid kinetics. Br J Clin Pharmacol 11: 423PGoogle Scholar
  19. 19.
    Suhardjono D, Boutagy J, Shenfield GM (1986) The effect of glucose on acetylation status. Br J Clin Pharmacol 22: 401–408Google Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • Y. Irshaid
    • 1
  • H. Al-Hadidi
    • 1
  • M. Abuirjeie
    • 3
  • A. Latif
    • 2
  • O. Sartawi
    • 2
  • N. Rawashdeh
    • 1
  1. 1.Department of Pharmacology Faculty of MedicineJordan University of Science and TechnologyIrbidJordan
  2. 2.Department of Internal Medicine, Faculty of MedicineJordan University of Science and TechnologyIrbidJordan
  3. 3.Department of Medicinal Chemistry, Faculty of PharmacyJordan University of Science and TechnologyIrbidJordan

Personalised recommendations